BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 17, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for Oct. 12, 2020

Oct. 12, 2020
New hires and promotions in the med-tech industry, including: Ambu, Brainomix.
Read More

Regulatory actions for Oct. 12, 2020

Oct. 12, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alexion, Avenue, Astrazeneca, Celltrion, Gannex, Immunomedics, Oncopeptides, Oxular.
Read More

Other news to note for Oct. 12, 2020

Oct. 12, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Altimmune, Antengene, Auravax, Bausch, Cstone, Curon, Eyenovia, Hitgen, Innocan, Ligand, Novabay, Pfizer, Rhizen, Wuxi.
Read More

In the clinic for Oct. 12, 2020

Oct. 12, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amicus, Amylyx, Astellas, Astrazeneca, Basilea, BMS, Celltrion, Galapagos, Gilead, Gossamer, Janssen, Kuur, Lilly, Rhovac, Seagen, Seres, Takeda, Vedanta.
Read More

Financings for Oct. 12, 2020

Oct. 12, 2020
Biopharmas raising money in public or private financings, including: Aligos, Atea, Immunogen, Opthea, SQZ, Tarsus, Virpax.
Read More

Appointments and advancements for Oct. 12, 2020

Oct. 12, 2020
New hires and promotions in the biopharma industry, including: Cerecor, Oncosec, OS Therapies.
Read More

Other news to note for Oct. 9, 2020

Oct. 9, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bruin Biometrics, Cytosorbents, Key Surgical, Steris, Wise Therapeutics.
Read More

Appointments and advancements for Oct. 9, 2020

Oct. 9, 2020
New hires and promotions in the med-tech industry, including: Dental Monitoring, Spectrawave.
Read More

Regulatory actions for Oct. 9, 2020

Oct. 9, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beckman Coulter, Genmark Diagnostics, Oxford Nanopore.
Read More

In the clinic for Oct. 9, 2020

Oct. 9, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Axon Therapies.
Read More
Previous 1 2 … 1450 1451 1452 1453 1454 1455 1456 1457 1458 … 1738 1739 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing